Oncogenic parallels in Alzheimer disease

International Journal of Neuroprotection and Neuroregeneration

Volumn 2, Issue 2, 2006, Pages 80-85

  Raina, Arun K ^a   Garrett, Matthew R ^a   Previll, Laura A ^a   Obrenovich, Mark E ^a   Hartzler, Anthony W ^a   Webber, Kate M ^a   Casadesus, Gemma ^a   Lee, Hyoung Gon ^a   Perry, George ^a   Zhu, Xiongwei ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Alzheimer disease; Apoptosis; Cell cycle; Cyclin dependent kinase; Oncogenesis; Oxidative stress; Presenilin 1

Indexed keywords

CYCLIN A; CYCLIN B; CYCLIN C; CYCLIN D; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 7; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; CYCLINE; KI 67 ANTIGEN; MYC PROTEIN; PROTEIN CDC42; PROTEIN P105; PROTEIN P107; PROTEIN P16; PROTEIN P21; PROTEIN P25; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE; RAF PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; CARCINOGENESIS; CELL CYCLE; CELL CYCLE M PHASE; DISEASE ASSOCIATION; DISEASE MARKER; DNA REPAIR; HUMAN; MITOSIS INHIBITION; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 33645681674     PISSN: 17451183     EISSN: 17451191     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Smith MA (1998) Alzheimer disease. Int Rev Neurobiol 42:1-54.
2. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79:551-555.
3. Zhu X, Raina AK, Boux H et al. (2000) Activation of oncogenic pathways in degenerating neurons in Alzheimer disease. Int J Dev Neurosci 18:433-437.
4. Zhu X, Rottkamp CA, Boux H et al. (2000) Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J Neuropathol Exp Neurol 59:880-888.
5. Zhu X, Rottkamp CA, Raina AK et al. (2000) Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease. Neurobiol Aging 21:807-813.
6. Raina AK, Zhu X, Monteiro M, Takeda A, Smith MA (2000) Abortive oncogeny and cell cycle-mediated events in Alzheimer disease. Prog Cell Cycle Res 4:235-242.
7. Raina AK, Zhu X, Rottkamp CA et al. (2000) Cyclin toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J Neurosci Res 61:128-133.
8. Smith TW, Lippa CF (1995) Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. J Neuropathol Exp Neurol 54:297-303.
9. Arendt T, Holzer M, Grossmann A, Zedlick D, Bruckner MK (1995) Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease. Neuroscience 68:5-18.
10. Arendt T, Rodel L, Gartner U, Holzer M (1996) Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport 7:3047-3049.
11. Vincent I, Jicha G, Rosado M, Dickson DW (1997) Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 17:3588-3598.
12. Vincent I, Rosado M, Davies P (1996) Mitotic mechanisms in Alzheimer's disease? J Cell Biol 132:413-425.
13. Vincent I, Zheng JH, Dickson DW, Kress Y, Davies P (1998) Mitotic phosphoepifopes precede paired helical filaments in Alzheimer's disease. Neurobiol Aging 19:287-296.
14. Nagy Z, Esiri MM, Cato AM, Smith AD (1997) Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol (Bert) 94:6-15.
15. Nagy Z, Esiri MM, Smith AD (1997) Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol (Bert) 93:294-300.
16. McShea A, Harris PL, Webster KR, Wahl AF, Smith MA (1997) Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol 150:1933-1939.
17. McShea A, Wahl AF, Smith MA (1999) Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease. Med Hypotheses 52:525-527.
18. McShea A, Zelasko DA, Gerst JL, Smith MA (1999) Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli. Brain Res 815:237-242.
19. Arendt T, Holzer M, Gartner U (1998) Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease. J Neural Transm 105:949-960.
20. Raina AK, Monteiro MJ, McShea A, Smith MA (1999) The role of cell cycle-mediated events in Alzheimer's disease. Int J Exp Pathol 80:71-76.
21. Raina AK, Takeda A, Smith MA (1999) Mitotic neurons: a dogma succumbs. Exp Neurol 159:248-249.
22. Zhu X, Raina AK, Smith MA (1999) Cell cycle events in neurons. Proliferation or death? Am J Pathol 155:327-329.
23. Yang Y, Geldmacher DS, Herrup K (2001) DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci 21:2661-2668.
24. Busser J, Geldmacher DS, Herrup K (1998) Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci 18:2801-2807.
25. Iqbal K, Zaidi T, Thompson CH, Merz PA, Wisniewski HM (1984) Alzheimer paired helical filaments: bulk isolation, solubility, and protein composition. Acta Neuropathol (Bert) 62:167-177.
26. Grundke-Iqbal I, Iqbal K, Tung YC et al. (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83:4913-4917.
27. Lindwall G, Cole RD (1984) Phosphorylation affects the ability of tau protein to promote microtubule assembly. J Biol Chem 259:5301-5305.
28. Alonso AC, Grundke-Iqbal I, Iqbal K (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 2:783-787.
29. Brion JP, Octave JN, Couck AM (1994) Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons. Neuroscience 63:895-909.
30. Brion JP, Passarier H, Nunez J, Flament-Durand J (1985) Immunologic determinants of tau protein are present in neurofibrillary tangles of Alzheimer's disease. Arch Biol 95:229-235.
31. Kanemaru K, Tokio K, Miura R, Titani K, Ihara Y (1992) Fetal-type phosphorylation of the tau in paired helical filaments. J Neurochem 58:1667-1675.
32. Goedert M, Jakes R, Crowther RA et al. (1993) The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci U S A 90:5066-5070.
33. Pope WB, Lambert MP, Leypold B et al. (1994) Micro tubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y. Exp Neurol 126:185-194.
34. Andorfer C, Acker CM, Kress Y et al. (2005) Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J Neurosci 25:5446-5454.
35. Ledoux S, Rebai N, Dagenais A et al. (1993) Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation. J Immunol 150:5566-5575.
36. Suzuki T, Oishi M, Marshak DR et al. (1994) Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. Embo J 13:1114-1122.
37. Chen Y, McPhie DL, Hirschberg J, Neve RL (2000) The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons. J Biol Chem 275:8929-8935.
38. Neve RL, McPhie DL, Chen Y (2000) Alzheimer's disease: a dysfunction of the amyloid precursor protein(1). Brain Res 886:54-66.
39. Bruni P, Minopoli G, Brancaccio T et al. (2002) Fe65, a ligand of the Alzheimer's beta-amyloid precursor protein, blocks cell cycle progression by down-regulating thymidylate synthase expression. J Biol Chem 277:35481-35488.
40. McDonald DR, Bamberger ME, Combs CK, Landreth GE (1998) beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J Neurosci 18:4451-4460.
41. Pyo H, Jou I, Jung S, Hong S, Joe EH (1998) Mitogen-activated protein kinases activated by lipopolysaccharide and beta-amyloid in cultured rat microglia. Neuroreport 9:871-874.
42. Giovanni A, Wirtz-Brugger F, Keramaris E, Slack R, Park DS (1999) Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F × DP, in B-amyloid-induced neuronal death. J Biol Chem 274:19011-19016.
43. Wong PC, Zheng H, Chen H et al. (1997) Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 387:288-292.
44. Struhl G, Greenwald I (1999) Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 398:522-525.
45. Ye Y, Lukinova N, Fortini ME (1999) Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants. Nature 398:525-529.
46. Li J, Xu M, Zhou H, Ma J, Potter H (1997) Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell 90:917-927.
47. Janicki SM, Stabler SM, Monteiro MJ (2000) Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest. Neurobiol Aging 21:829-836.
48. Soriano S, Kang DE, Fu M et al. (2001) Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing. J Cell Biol 152:785-794.
49. Yuasa S, Nakajima M, Aizawa H et al. (2002) Impaired cell cycle control of neuronal precursor cells in the neocortical primordium of presenilin-1-deficient mice. J Neurosci Res 70:501-513.
50. Mattson MP, Guo Q, Furukawa K, Pedersen WA (1998) Presenilins, the endoplasmic reticulum, and neuronal apoptosis in Alzheimer's disease. J Neurochem 70:1-14.
51. Wolozin B, Iwasaki K, Vito P et al. (1996) Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science 274:1710-1713.
52. Janicki S, Monteiro MJ (1997) Increased apoptosis arising from increased expression of the Alzheimer's disease-associated presenilin-2 mutation (N1411). J Cell Biol 139:485-495.
53. Slooter AJ, Tang MX, van Duijn CM et al. (1997) Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. Jama 277:818-821.
54. Steusloff K, Rocken C, Saeger W (1998) Basement membrane proteins, apolipoprotein E and glycosaminoglycans in pituitary adenomas and their correlation to amyloid. Virchows Arch 433:29-34.
55. Feddersen RM, Clark HB, Yunis WS, Orr HT (1995) In vivo viability of postmitotic Purkinje neurons requires pRb family member function. Mol Cell Neurosci 6:153-167.
56. Park DS, Obeidat A, Giovanni A, Greene LA (2000) Cell cycle regulators in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment. Neurobiol Aging 21:771-781.
57. Smith MA, Sayre LM, Monnier VM, Perry G (1995) Radical AGEing in Alzheimer's disease. Trends Neurosci 18:172-176.
58. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23:134-147.
59. Perry G, Castellani RJ, Hirai K, Smith MA (1998) Reactive oxygen species mediate cellular damage in Alzheimer disease. J Alzheimers Dis 1:45-55.
60. Curcio F, Ceriello A (1992) Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. In Vitro Cell Dev Biol 28A:787-790.
61. Ferrari G, Yan CY, Greene LA (1995) N-acetylcysteine (D- and L-stereoisomers) prevents apoptotic death of neuronal cells. J Neurosci 15:2857-2866.
62. Barni S, Sciola L, Spano A, Pippia P (1996) Static cytofluorometry and fluorescence morphology of mitochondria and DNA in proliferating fibroblasts. Biotech Histochem 71:66-70.
63. Nunomura A, Perry G, Aliev G et al. (2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60:759-767.
64. Sousa M, Barros A, Silva J, Tesarik J (1997) Developmental changes in calcium content of ultra-structurally distinct subcellular compartments of preimplantation human embryos. Mol Hum Reprod 3:83-90.
65. Hirai K, Aliev G, Nunomura A et al. (2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21:3017-3023.
66. Park DS, Morris EJ, Padmanabhan J et al. (1998) Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J Cell Biol 143:457-467.
67. Raina AK, Hochman A, Zhu X et al. (2001) Abortive apoptosis in Alzheimer's disease. Acta Neuropathol (Berl) 101:305-310.
68. Zhu X, McShea A, Harris PL et al. (2004) Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease. J Neurosci Res 75:698-703.
69. Perry G, Roder H, Nunomura A et al. (1999) Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport 10:2411-2415.
70. Obrenovich ME, Raina AK, Ogawa O, Atwood CS, Smith MA. Alzheimer disease - a new beginning, or a final exit? In: Copani A, Nicoletti F, editors. The Cell Cycle and Neuronal Cell Death. Georgestown, Texas: Landes Bioscience; 2005. p. 79-93.